Molecular Pharmaceutics

Papers
(The H4-Index of Molecular Pharmaceutics is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer via NIRF Imaging259
High Molecular Weight Poly(glutamic acid) to Improve BMP2-Induced Osteogenic Differentiation124
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models120
[68Ga]Ga-HM or [68Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?115
A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections113
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement112
Mechanical Extrusion of the Plasma Membrane to Generate Ectosome-Mimetic Nanovesicles for Lung Targeting90
Effects of Lyophilization, Vacuum Drying, and Microglassification on Two Model Proteins Assessed at the Residue Level Using Liquid Observed Vapor Exchange Nuclear Magnetic Resonance Spectroscopy (LOVE86
Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development82
Issue Editorial Masthead77
Issue Editorial Masthead74
Issue Publication Information70
Deconstructing Annealing Phenomena in Modified Release Lipid Multiparticulates67
Correction to “Effects of PEGylation on Imaging Contrast of 68Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4”67
Characterization of Human Intestinal Fluids after the Administration of a Solid Meal60
Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment60
Correction to Reshaping Tumor Blood Vessels to Enhance Drug Penetration with a Multistrategy Synergistic Nanosystem60
In Vitro Release from Polymeric Core/Shell Nanoparticles through the Lens of Multiscale Modeling59
Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications58
64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer54
Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants50
Revolutionizing Neurological Therapies: The Multifaceted Potential of Zein-Based Nanoparticles for Brain-Targeted Drug Delivery49
Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation49
Immuno-PET Imaging of TNF-α in Colitis Using 89Zr-DFO-infliximab48
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide46
Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole44
Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence44
Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection44
Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn2+/Mn4+ and Mo5+/Mo6+) for Augmented Cancer T43
Difference in Endocytosis Pathways Used by Differentiated Versus Nondifferentiated Epithelial Caco-2 Cells to Internalize Nanosized Particles43
The Dawn of a New Era: Tumor-Targeting Boron Agents for Neutron Capture Therapy43
Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma Model42
Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin42
Monoclonal Antibody Delivery Using 3D Printed Biobased Hollow μNe3dle Arrays for the Treatment of Osteoporosis41
A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines41
Fluorescent Self-Reporting Lipid Nanoparticles for Nitric Oxide/Gene Co-Delivery and Combination Therapy40
Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment40
Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms40
Structured Sponsorship: An Option for Improved Workplace Inclusion in the Pharmaceutical Sciences40
Effect of Moisture Sorption and Lactose Type on Tablet Quality: A Hygroscopicity Study between Lactose Powder and Tablets40
0.20010089874268